VRSN Form 4: Courtney Armstrong Receives 879 Immediately-Vesting RSUs

Rhea-AI Filing Summary

VeriSign (VRSN) Form 4: Director Courtney D. Armstrong reported the award of 879 restricted stock units (RSUs) on 07/21/2025. Each RSU converts into one share and vested 100% on the grant date; therefore the transaction code is "A" (acquisition) at a grant price of $0. After settlement, Armstrong, through The Armstrong Family Trust, now beneficially owns 6,047.775 VeriSign common shares. No derivative securities were involved and there was no open-market purchase or sale. The filing represents routine equity compensation for a board member and increases Armstrong’s stake by an immaterial amount relative to VeriSign’s total shares outstanding.

Insights

Securities Analyst

TL;DR: Minor RSU grant; immaterial to float and valuation—neutral signal.

The 879-share RSU grant is a standard element of board compensation, not an open-market buy that would indicate incremental bullishness. Post-grant ownership of 6,048 shares remains de-minimis versus VeriSign’s roughly 104 million shares outstanding, so dilution and insider-alignment effects are negligible. From a trading perspective this Form 4 should have no meaningful price impact and does not alter the investment thesis.

Corporate Governance Expert

TL;DR: Routine equity award aligns director incentives; governance impact neutral.

Granting immediately-vesting RSUs is common practice to remunerate directors while fostering share ownership. Although vest-on-grant plans raise some concerns about long-term retention, Armstrong already holds the shares via a family trust, maintaining alignment with shareholder interests. No red flags—report fully complies with Section 16 disclosure requirements.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Armstrong Courtney D

(Last) (First) (Middle)

12061 BLUEMONT WAY

(Street)

RESTON VA 20190

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VERISIGN INC/CA [ VRSN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/21/2025		A		879(1)	A	$0	6,047.775	I	by The Armstrong Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On July 21, 2025, Reporting Person was awarded restricted stock units (RSUs). Each RSU represents a contingent right to receive one (1) share of VeriSign, Inc. common stock once vested. The grant vests 100% on the date of grant, subject to applicable taxes upon delivery.

Remarks:

	Thomas C. Indelicarto by Power of Attorney for Courtney D. Armstrong	07/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did VeriSign director Courtney D. Armstrong report in the latest Form 4?

Armstrong disclosed the receipt of 879 immediately-vesting RSUs on 07/21/2025.

How many VeriSign shares does Armstrong own after the transaction?

Post-grant, Armstrong indirectly holds 6,047.775 common shares through The Armstrong Family Trust.

Was the RSU grant an open-market purchase?

No. The RSUs were granted by the company at a price of $0; no cash changed hands.

Does this Form 4 signal significant insider buying or selling at VeriSign (VRSN)?

No. It reflects routine board compensation and is immaterial to the company’s share count.

Will the 879 new shares materially dilute existing VeriSign shareholders?

The share increase is negligible relative to VeriSign’s outstanding shares and should not affect dilution metrics.